CO4940444A1 - Esteres y amidas de fenil xantina - Google Patents

Esteres y amidas de fenil xantina

Info

Publication number
CO4940444A1
CO4940444A1 CO98007044A CO98007044A CO4940444A1 CO 4940444 A1 CO4940444 A1 CO 4940444A1 CO 98007044 A CO98007044 A CO 98007044A CO 98007044 A CO98007044 A CO 98007044A CO 4940444 A1 CO4940444 A1 CO 4940444A1
Authority
CO
Colombia
Prior art keywords
xantina
amides
esters
phenyl
integer
Prior art date
Application number
CO98007044A
Other languages
English (en)
Spanish (es)
Inventor
Susan Mary Daluge
Gerald Wolberg
Douglas Alan Livingston
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CO4940444A1 publication Critical patent/CO4940444A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CO98007044A 1997-02-14 1998-02-11 Esteres y amidas de fenil xantina CO4940444A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9703044.9A GB9703044D0 (en) 1997-02-14 1997-02-14 Phenyl xanthine esters and amides

Publications (1)

Publication Number Publication Date
CO4940444A1 true CO4940444A1 (es) 2000-07-24

Family

ID=10807635

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98007044A CO4940444A1 (es) 1997-02-14 1998-02-11 Esteres y amidas de fenil xantina

Country Status (38)

Country Link
US (3) US6355646B1 (sh)
EP (1) EP0970081B1 (sh)
JP (1) JP2001511792A (sh)
KR (1) KR100522639B1 (sh)
CN (1) CN1140527C (sh)
AP (1) AP1000A (sh)
AR (1) AR011441A1 (sh)
AT (1) ATE304542T1 (sh)
AU (1) AU754456B2 (sh)
BG (1) BG103722A (sh)
BR (1) BR9807682B1 (sh)
CA (1) CA2280730C (sh)
CO (1) CO4940444A1 (sh)
CZ (1) CZ298764B6 (sh)
DE (1) DE69831559T2 (sh)
DK (1) DK0970081T3 (sh)
EA (1) EA199900648A1 (sh)
EE (1) EE9900348A (sh)
ES (1) ES2249822T3 (sh)
GB (1) GB9703044D0 (sh)
HK (1) HK1022907A1 (sh)
HR (1) HRP980077A2 (sh)
HU (1) HU225962B1 (sh)
ID (1) ID22770A (sh)
IL (1) IL131179A (sh)
IS (1) IS5144A (sh)
MY (1) MY118545A (sh)
NO (1) NO325685B1 (sh)
NZ (1) NZ336923A (sh)
PE (1) PE58899A1 (sh)
PL (1) PL188018B1 (sh)
SK (1) SK110399A3 (sh)
TR (1) TR199901942T2 (sh)
TW (1) TW520371B (sh)
UA (1) UA57767C2 (sh)
WO (1) WO1998035966A1 (sh)
YU (1) YU38399A (sh)
ZA (1) ZA981175B (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
US6545002B1 (en) * 1999-06-01 2003-04-08 University Of Virginia Patent Foundation Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
ES2262798T3 (es) * 2001-02-28 2006-12-01 Smithkline Beecham Corporation Derivados glicolicos de xantinas para tratar el sindrome del intestino irritable.
US20080318983A1 (en) * 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20040072848A1 (en) * 2002-02-26 2004-04-15 Huber Brian E Methods of treating irritable bowel syndrome and functional dyspepsia
AU2012227249B2 (en) * 2003-12-16 2014-10-02 Nektar Therapeutics Chemically modified small molecules
PL1694363T3 (pl) * 2003-12-16 2014-07-31 Nektar Therapeutics Monodyspersyjne kompozycje PEGylowanego naloksolu
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
WO2005102976A1 (en) * 2004-04-21 2005-11-03 Smithkline Beecham Corporation Process for preparing nonaethylene glycol monomethyl ether
WO2006028810A2 (en) * 2004-09-01 2006-03-16 Cv Therapeutics, Inc. Method of wound healing using a2b adenosine receptor antagonists
US20070059740A1 (en) * 2005-08-26 2007-03-15 Linden Joel M Method of targeting a2b adenosine receptor antagonist therapy
US8193200B2 (en) * 2007-01-04 2012-06-05 University Of Virginia Patent Foundation Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8510758D0 (en) 1985-04-27 1985-06-05 Wellcome Found Compounds
US4968672A (en) 1987-01-02 1990-11-06 The United States Of America As Represented By The Department Of Health And Human Services Adenosine receptor prodrugs
US5015647A (en) 1987-04-24 1991-05-14 Burroughs Wellcome Co. Method for treating viral infections
GB8826595D0 (en) 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
NZ240644A (en) 1990-11-21 1994-08-26 Smithkline Beecham Corp Use of xanthine derivatives to inhibit the production of tumour necrosis factor (tnf)
GB9210839D0 (en) * 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
TW252044B (sh) * 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
GB9415529D0 (en) 1994-08-01 1994-09-21 Wellcome Found Phenyl xanthine derivatives
DE19535504A1 (de) 1995-09-25 1997-03-27 Bayer Ag Substituierte Xanthine
SI0812844T1 (en) 1996-06-07 2003-02-28 Hoechst Aktiengesellschaft Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
US6117878A (en) 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
WO1999043673A1 (fr) 1998-02-26 1999-09-02 Zenyaku Kogyo Kabushiki Kaisha Derives de 1-aza-indolizine
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
NZ519781A (en) 1999-12-23 2004-04-30 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
US6751206B1 (en) * 2000-06-29 2004-06-15 Qualcomm Incorporated Method and apparatus for beam switching in a wireless communication system

Also Published As

Publication number Publication date
CA2280730A1 (en) 1998-08-20
GB9703044D0 (en) 1997-04-02
JP2001511792A (ja) 2001-08-14
CN1140527C (zh) 2004-03-03
IL131179A0 (en) 2001-01-28
ID22770A (id) 1999-12-09
DE69831559D1 (de) 2005-10-20
PL188018B1 (pl) 2004-11-30
YU38399A (sh) 2002-06-19
ZA981175B (en) 1999-08-12
EP0970081A1 (en) 2000-01-12
US6437124B1 (en) 2002-08-20
PL335135A1 (en) 2000-04-10
AU6622198A (en) 1998-09-08
NO993915D0 (no) 1999-08-13
UA57767C2 (uk) 2003-07-15
BG103722A (en) 2000-06-30
KR100522639B1 (ko) 2005-10-19
TR199901942T2 (xx) 1999-12-21
EA199900648A1 (ru) 2000-04-24
US6355646B1 (en) 2002-03-12
ATE304542T1 (de) 2005-09-15
US20030181471A1 (en) 2003-09-25
IS5144A (is) 1999-07-30
NZ336923A (en) 2001-02-23
DK0970081T3 (da) 2006-02-06
EP0970081B1 (en) 2005-09-14
CN1252071A (zh) 2000-05-03
TW520371B (en) 2003-02-11
AU754456B2 (en) 2002-11-14
SK110399A3 (en) 2000-06-12
BR9807682B1 (pt) 2009-01-13
DE69831559T2 (de) 2006-06-14
NO325685B1 (no) 2008-07-07
HUP0000894A2 (hu) 2001-05-28
KR20000071010A (ko) 2000-11-25
EE9900348A (et) 2000-02-15
HK1022907A1 (en) 2000-08-25
HRP980077A2 (en) 1998-12-31
WO1998035966A1 (en) 1998-08-20
CA2280730C (en) 2006-10-10
US7002012B2 (en) 2006-02-21
PE58899A1 (es) 1999-06-17
BR9807682A (pt) 2000-02-15
HU225962B1 (en) 2008-01-28
HUP0000894A3 (en) 2002-04-29
IL131179A (en) 2004-05-12
AP9901622A0 (en) 1999-09-30
AP1000A (en) 2001-08-11
CZ298764B6 (cs) 2008-01-23
AR011441A1 (es) 2000-08-16
ES2249822T3 (es) 2006-04-01
NO993915L (no) 1999-10-13
CZ288799A3 (cs) 2000-04-12
MY118545A (en) 2004-12-31

Similar Documents

Publication Publication Date Title
CO4940444A1 (es) Esteres y amidas de fenil xantina
TW334418B (en) Stilbene derivatives and pharmaceutical compositions
GR3023130T3 (en) Phosphotriester-type biologically active compounds.
UA50766C2 (uk) Композиція для полоскання ротової порожнини, яка вміщує хлористий цетилпіридин та амфотерний сурфактант
MY132251A (en) Methods of inhibiting cell-cell adhesion
ES2172093T3 (es) Nuevas composiciones cosmeticas que comprenden un polimero filmogeno.
ES2184326T3 (es) Nuevos compuestos derivados del mentol y su utilizacion como agente refrescante.
ZA984635B (en) Orally active iron (III) chelators.
ES2010853A6 (es) Composiciones de tensoactivos sinergicos.
YU40592A (sh) Estri fenolnih 2-piperidino-1-alkanola
HU9503270D0 (en) Nipecotic acid derivatives as antithrombic compounds
MX9801190A (es) Inhibidores de prolil endopeptidasa.
ES8800287A1 (es) Procedimiento de preparar copolimeros formadores de pelicula
MX9803901A (es) Compuestos de di-terbutilfenol que contienen azufre utiles como agentes anti-inflamatorios.
DE3662883D1 (en) Guanidinobenzoic ester derivative, a process for preparing same and pharmaceutical compositions containing same
DE69328774D1 (de) Herstellung von körnigen alkalimetallborat-zusammensetzungen
MY105684A (en) Skin detergent composition
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
EP0508623A3 (en) Peroxyacids
IT1263751B (it) Derivati di esteri arilacetici ad attivita' fungicida
IL124738A (en) Stabilized hydroxylamine solutions
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
IT1269584B (it) Procedimento per la preparazione di derivati di 5,6-diidrossi- 2-ammino-1,2,3,4- tetraidronaftalene
TW329388B (en) Intraocular irrigating solution